Tags |
|
|
Links |
|
|
Member You - Intellectual Property
Homeowner loans are a type of loan that offers the lender increased security. The lender gives the homeowner money and receives property as collateral. It is called a homeowner loan because it is often used by homeowners and the property offered as collateral is oftentimes the home. If a homeowner loan is not paid off, the lender can seize the property in order to get his or her money back. Homeowner loans are sometimes referred to as a “secured loan” because
Primarily as an effort to boost U.S. eminence and competitiveness to the then fledgling but growing biotech industry, shortly after the Diamond vs. Chakraborty decision the U.S. Patent Office (USPTO) began issuing patents on products of nature including genes (human or otherwise), gene fragments, cell lines, proteins and other naturally occurring substances.
A quick story:During the annual meeting, the CEO of a manufacturing company informed her executive team that she wanted to achieve a 10% growth during the next 12 months. The VP of Operations made plans to purchase new manufacturing equipment for new products while the VP of Marketing & Sales began to implement a plan selling existing products. The CFO decided to cut budgets to capital improvements and marketing. All three executive team members believe
Intellectual Property includes patents, trademarks, service marks, copyrights, and trade secrets. This value-added asset can be sold, bought and traded as a part of everyday commerce.
It is important for a company to know what IP it has and how to enhance the company's IP position which, in turn, enhances the company's valuation.
Patents are often the most valuable IP asset for most companies. Strictly speaking there are three types of U.S. patents:
(1) Design Patents (for example, an ornamental design for an article of manufacture)
(2) Plant Patents (for example, an asexually produced flower or plant)
(3) Utility Patents
The most common patent for technology-based companies are utility patents. Utility patents are granted to inventors according to the Patent Act, which can be found at Title 35 of the United States Code (U.S.C.) and states as follows:
"Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefore, subject to the conditions and requirements of this title." (35 U.S.C., §101)
Equally as important as what is patentable is what is not patentable. What are not patentable are:
(1) Laws of nature
(2) Physical phenomena
(3) Abstract ideas
(4) Products of nature
However, what constitutes patentable subject matter has come under broad interpretation as a result of the U.S. Supreme Court decision in Diamond vs. Chakraborty (1980), which established that companies or individuals could receive utility patents for newly created organisms. Since then, the biotechnology industry has argued that patents should issue on genes, proteins and other natural materials which have commercial value.
Primarily as an effort to boost U.S. eminence and competitiveness to the then fledgling but growing biotech industry, shortly after the Diamond vs. Chakraborty decision the U.S. Patent Office (USPTO) began issuing patents on products of nature including genes (human or otherwise), gene fragments, cell lines, proteins and other naturally occurring substances.
<Some would say about certain issues that the means do not justify the ends. Well more often the ends do not justify the means. For instance if you are trying to accomplish something and know that if you do use the most approved PC methods then you cannot get to the desired results, but use those methods anyway as to not appear to offend anyone, then in the end you offend everyone by wasting their time and by failure of the project.What we must do is to
Patents are often the most valuable IP asset for most companies. Strictly speaking there are three types of U.S. patents:
(1) Design Patents (for example, an ornamental design for an article of manufacture)
(2) Plant Patents (for example, an asexually produced flower or plant)
(3) Utility Patents
The most common patent for technology-based companies are utility patents. Utility patents are granted to inventors according to the Patent Act, which can be found at Title 35 of the United States Code (U.S.C.) and states as follows:
"Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefore, subject to the conditions and requirements of this title." (35 U.S.C., §101)
Equally as important as what is patentable is what is not patentable. What are not patentable are:
(1) Laws of nature
(2) Physical phenomena
(3) Abstract ideas
(4) Products of nature
However, what constitutes patentable subject matter has come under broad interpretation as a result of the U.S. Supreme Court decision in Diamond vs. Chakraborty (1980), which established that companies or individuals could receive utility patents for newly created organisms. Since then, the biotechnology industry has argued that patents should issue on genes, proteins and other natural materials which have commercial value.
Primarily as an effort to boost U.S. eminence and competitiveness to the then fledgling but growing biotech industry, shortly after the Diamond vs. Chakraborty decision the U.S. Patent Office (USPTO) began issuing patents on products of nature including genes (human or otherwise), gene fragments, cell lines, proteins and other naturally occurring substances.
Many people consider page rank a kind of talisman that will magically take them to the top of the search engines. In reality, it just isn’t that important for most people.Why isn’t page rank important? Because it has no direct effect on your positioning in the search engines. Page rank doesn’t mater in terms of where you’re going to show up, and where you show up is the major determiner of your revenue. Many people focus on page rank to the exclusion of
"Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefore, subject to the conditions and requirements of this title." (35 U.S.C., §101)
Equally as important as what is patentable is what is not patentable. What are not patentable are:
(1) Laws of nature
(2) Physical phenomena
(3) Abstract ideas
(4) Products of nature
However, what constitutes patentable subject matter has come under broad interpretation as a result of the U.S. Supreme Court decision in Diamond vs. Chakraborty (1980), which established that companies or individuals could receive utility patents for newly created organisms. Since then, the biotechnology industry has argued that patents should issue on genes, proteins and other natural materials which have commercial value.
Primarily as an effort to boost U.S. eminence and competitiveness to the then fledgling but growing biotech industry, shortly after the Diamond vs. Chakraborty decision the U.S. Patent Office (USPTO) began issuing patents on products of nature including genes (human or otherwise), gene fragments, cell lines, proteins and other naturally occurring substances.
Ten Money Saving Tips for Print ManagersDespite their stated desire to realize savings from streamlining the various components associated with the print buying process, it’s been my experience over the years, that many print managers neglect to do some of the easy things that can add up to significant cost savings annually. We all know these things, but we don’t always do them. Below are a few tips for saving money on print jobs, which might be old ha
(1) Laws of nature
(2) Physical phenomena
(3) Abstract ideas
(4) Products of nature
However, what constitutes patentable subject matter has come under broad interpretation as a result of the U.S. Supreme Court decision in Diamond vs. Chakraborty (1980), which established that companies or individuals could receive utility patents for newly created organisms. Since then, the biotechnology industry has argued that patents should issue on genes, proteins and other natural materials which have commercial value.
Primarily as an effort to boost U.S. eminence and competitiveness to the then fledgling but growing biotech industry, shortly after the Diamond vs. Chakraborty decision the U.S. Patent Office (USPTO) began issuing patents on products of nature including genes (human or otherwise), gene fragments, cell lines, proteins and other naturally occurring substances.
Looking at various news articles and comments on the web in the last month it would appear that;* UK employers are about to be hit by a massive skills shortage!* The job market is bound for massive expansion as companies and organisations take the dust covers off their delayed investments in new IT systems and regulatory adherence demands change!* The general consensus would appear to be that this skills shortage will convert into pay incr
Primarily as an effort to boost U.S. eminence and competitiveness to the then fledgling but growing biotech industry, shortly after the Diamond vs. Chakraborty decision the U.S. Patent Office (USPTO) began issuing patents on products of nature including genes (human or otherwise), gene fragments, cell lines, proteins and other naturally occurring substances.
As a result of increasingly growing criticism, the USPTO has recently issued utility patent guidelines and rules regarding a stricter definition of what is invented or patentable. These new guidelines and rules call for utility patents to have "specific and substantial utility that is credible."
No longer will it be sufficient to claim that a particular biological or molecular probe (DNA, protein, etc.) to be a useful probe, the new utility test calls for specific utility regarding that particular molecular probe (i.e., a probe for a particular gene, a probe for a specific disease state or a probe for a defined location on a chromosome).
In addition, it is no longer acceptable to make general claims regarding utility and usefulness. For example, it will not be acceptable to claim that a protein is a source of amino acids or a feed supplement or a dietary supplement, but real-world utility must be specified and demonstrated.
The new utility patent guidelines and rules will have a profound effect on the biotech and related industries.
Visit www.BusinessOfScience.com for additional information concerning Intellectual Property and the business of science and technology.
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.memberyou.net/article/130179/memberyou-Intellectual-Property.html">Intellectual Property</a>
BB link (for phorums):
[url=http://www.memberyou.net/article/130179/memberyou-Intellectual-Property.html]Intellectual Property[/url]
Related Articles:
Keep Your Business Running Optimally With Business Coaching
Affiliate Marketing - Does It Really Pay?
List Building With Search Engine Traffic I
Bookmark it:
|